Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human immunodeficiency virus type 1 polymerase protein (HIV-1 Pol)
- Target
- HIV-1 Pol
- Molecular classification
- Enzyme
01
Overview
The HIV-1 Pol protein is a polyprotein precursor that encodes for three essential enzymes: reverse transcriptase (RT), integrase (IN), and protease (PR). RT is responsible for converting the viral RNA genome into DNA, IN integrates this DNA into the host genome, and PR processes the polyprotein into mature enzymes. The Pol protein plays a crucial role in the replication cycle of HIV-1 and is a key target for antiretroviral therapies.
- Other names
- HIV-1 Pol polyproteinHIV-1 polymerase precursor
02
Mechanism of action
Inhibition of reverse transcription and proteolytic processing
03
Biological functions
Viral replicationreverse transcriptionintegration into host genomeproteolytic processing
04
Disease associations
Infection (HIV/AIDS)
05
Safety considerations
Resistance developmentside effects from antiretroviral therapy
06
Interacting drugs
Antiretroviral drugs such as reverse transcriptase inhibitors (e.g., zidovudine, lamivudine) and protease inhibitors (e.g., lopinavir, ritonavir)
07
Biomarkers
HIV viral loadCD4 cell count
Beyond the preview
Go deeper on Human immunodeficiency virus type 1 polymerase protein (HIV-1 Pol).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Human immunodeficiency virus type 1 polymerase protein (HIV-1 Pol).